• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

MDR tuberculosis--critical steps for prevention and control.

作者信息

Nathanson Eva, Nunn Paul, Uplekar Mukund, Floyd Katherine, Jaramillo Ernesto, Lönnroth Knut, Weil Diana, Raviglione Mario

机构信息

Stop TB Department, World Health Organization, Geneva, Switzerland.

出版信息

N Engl J Med. 2010 Sep 9;363(11):1050-8. doi: 10.1056/NEJMra0908076.

DOI:10.1056/NEJMra0908076
PMID:20825317
Abstract
摘要

相似文献

1
MDR tuberculosis--critical steps for prevention and control.耐多药结核病——预防与控制的关键步骤
N Engl J Med. 2010 Sep 9;363(11):1050-8. doi: 10.1056/NEJMra0908076.
2
Controlling multidrug-resistant tuberculosis and access to expensive drugs: a rational framework.控制耐多药结核病与获取昂贵药物：一个合理框架
Bull World Health Organ. 2002;80(6):489-95; discussion 495-500.
3
Programmatic management of multidrug resistant TB.耐多药结核病的规划管理
Indian J Tuberc. 2009 Oct;56(4):171-3.
4
Time to put boots on the ground: making universal access to MDR-TB treatment a reality.是时候采取实际行动了：让耐多药结核病治疗普及成为现实。
Int J Tuberc Lung Dis. 2010 Oct;14(10):1222-5.
5
The major infectious diseases in the world--to treat or not to treat?
N Engl J Med. 2001 Jul 19;345(3):208-10. doi: 10.1056/NEJM200107193450310.
6
The forgotten plague.被遗忘的瘟疫。
Time. 2008 Oct 13;172(15):55-61.
7
Multidrug-resistant tuberculosis (MDR-TB) in India: an attempt to link biosocial determinants.印度的耐多药结核病（MDR-TB）：一项关联生物社会决定因素的尝试。
J Public Health Policy. 2005 Apr;26(1):96-114. doi: 10.1057/palgrave.jphp.3200014.
8
Picking up the pace--scale-up of MDR tuberculosis treatment programs.加快步伐——扩大耐多药结核病治疗项目
N Engl J Med. 2010 Nov 4;363(19):1781-4. doi: 10.1056/NEJMp1010023.
9
XDR tuberculosis--implications for global public health.广泛耐药结核病——对全球公共卫生的影响
N Engl J Med. 2007 Feb 15;356(7):656-9. doi: 10.1056/NEJMp068273.
10
Slow elimination of multidrug-resistant tuberculosis.耐多药结核病的缓慢清除。
Sci Transl Med. 2009 Oct 21;1(3):3ra8. doi: 10.1126/scitranslmed.3000346.

引用本文的文献

1
Multidrug-resistant tuberculosis clusters and transmission in Taiwan: a population-based cohort study.台湾地区耐多药结核病聚集性病例及传播情况：一项基于人群的队列研究
Front Microbiol. 2024 Sep 18;15:1439532. doi: 10.3389/fmicb.2024.1439532. eCollection 2024.
2
Factors associated with tuberculosis drug resistance among presumptive multidrug resistance tuberculosis patients identified in a DRTB surveillance study in western Kenya.在肯尼亚西部进行的耐多药结核病监测研究中确定的疑似耐多药结核病患者中与结核耐药相关的因素。
J Clin Tuberc Other Mycobact Dis. 2024 Aug 2;37:100466. doi: 10.1016/j.jctube.2024.100466. eCollection 2024 Dec.
3
Opinion review of drug resistant tuberculosis in West Africa: tackling the challenges for effective control.
西非耐药结核病意见综述：应对有效控制的挑战。
Front Public Health. 2024 May 16;12:1374703. doi: 10.3389/fpubh.2024.1374703. eCollection 2024.
4
Drug Susceptibility and Mutation Profiles in Mycobacterium tuberculosis Isolates from a Tertiary Care Hospital in Kerala, India.印度喀拉拉邦一家三级保健医院分离的结核分枝杆菌的药物敏感性和突变特征。
Am J Trop Med Hyg. 2024 May 21;111(1):161-167. doi: 10.4269/ajtmh.24-0042. Print 2024 Jul 3.
5
Prevalence, Transmission and Genetic Diversity of Pyrazinamide Resistance Among Multidrug-Resistant Isolates in Hunan, China.中国湖南耐多药分离株中吡嗪酰胺耐药的流行情况、传播及遗传多样性
Infect Drug Resist. 2024 Feb 1;17:403-416. doi: 10.2147/IDR.S436161. eCollection 2024.
6
Universal drug-susceptibility testing of first-line drugs to preserve their efficacy: An essential strategy to defeat tuberculosis.对一线药物进行普遍药敏试验以保持其疗效：战胜结核病的一项基本策略。
J Clin Tuberc Other Mycobact Dis. 2023 Aug 22;33:100394. doi: 10.1016/j.jctube.2023.100394. eCollection 2023 Dec.
7
Unsuccessful treatment outcome and associated risk factors. A prospective study of DR-TB patients from a high burden country, Pakistan.治疗失败结局及其相关危险因素。来自高负担国家巴基斯坦的耐多药结核病患者的前瞻性研究。
PLoS One. 2023 Aug 10;18(8):e0287966. doi: 10.1371/journal.pone.0287966. eCollection 2023.
8
Association between overweight/obesity and multidrug-resistant tuberculosis.超重/肥胖与耐多药结核病之间的关联。
Rev Peru Med Exp Salud Publica. 2023 Jan-Mar;40(1):59-66. doi: 10.17843/rpmesp.2023.401.12138. Epub 2023 Jun 23.
9
Impact of Anti-Tuberculosis Drug Use on Treatment Outcomes in Patients with Pulmonary Fluoroquinolone-Resistant Multidrug-Resistant Tuberculosis: A Nationwide Retrospective Cohort Study with Propensity Score Matching.抗结核药物使用对耐氟喹诺酮类多药耐药肺结核患者治疗结局的影响：一项采用倾向评分匹配的全国性回顾性队列研究
Tuberc Respir Dis (Seoul). 2023 Jul;86(3):234-244. doi: 10.4046/trd.2023.0040. Epub 2023 May 31.
10
Dimethyl itaconate is effective in host-directed antimicrobial responses against mycobacterial infections through multifaceted innate immune pathways.衣康酸二甲酯通过多方面的固有免疫途径，在针对分枝杆菌感染的宿主导向性抗菌反应中有效。
Cell Biosci. 2023 Mar 8;13(1):49. doi: 10.1186/s13578-023-00992-x.